Assoc. Prof. Serhat
Tozburun

Serhat Tozburun received his B.S. degree in Physics from Middle East Technical University in 2005, an M.S. degree in Physics from Koç University in 2007, and a Ph.D. degree in the Optical Science and Engineering from the University of North Carolina, Charlotte in 2012, respectively. After PhD graduation, he joined the Wellman Center for Photomedicine at Massachusetts General Hospital and Harvard Medical School to participate in innovative research studies of the development of optically subsampled optical coherence tomography and a rapid, phase-stable optical coherence tomography system. At Wellman Center, he also focused on developing a method using novel apparatus for the treatment of Barrett’s esophagus, which is a precancerous condition of the esophagus and associated with esophageal cancer. Currently, he is a faculty member at Dokuz Eylul University and is appointed as the principal investigator at İzmir Biomedicine and Genome Center (IBG). At IBG, He established the Biophotonics and Optical Imaging Research Group in 2016. The broad goal of the research group is to develop and implement optical techniques and non-invasive optical coherence imaging modalities to address biomedical challenges. Dr. Tozburun serves as a reviewer of the Journal of Biomedical Optics, Optics Express, Biomedical Optics Express, Applied Optics, and Optics Letter. He is a Marie Skłodowska-Curie Actions (MSCA) fellow. He is also a member of the Institute of Electrical and Electronics Engineers – IEEE, the Optica – OSA, and the International Society for Optics and Photonics – SPIE. He has been awarded a 2012 Optics and Photonics Scholarship by SPIE for his potential contributions to the fields of optics and photonics, a 2016 Eser Tumen Outstanding Achievement Award by Fevzi Akkaya scientific activities support fund (FABED), a 2018 Young Scientist Award Program (GEBIP) Grantee by Turkish Academy of Science (TUBA), and a 2020 Young Scientist Awards Program (BAGEP) Grantee by Science Academy. Dr. Tozburun holds three patents and has more than 50 papers published in refereed scientific journals and conference proceedings. He is co-founder of a start-up company titled Healysense AS.